These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9546415)

  • 21. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-glycosphingolipid autoantibodies in rheumatologic disorders.
    Zeballos RS; Fox RI; Cheresh DA; McPherson RA
    J Clin Lab Anal; 1994; 8(6):378-84. PubMed ID: 7869176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to human heart conduction system in Chagas' disease.
    Arce-Fonseca M; Ballinas-Verdugo MA; Reyes PA; Aranda-Fraustro A; Monteón VM
    Vector Borne Zoonotic Dis; 2005; 5(3):233-6. PubMed ID: 16187891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ganglioside reactive antibodies in the neuropathy associated with celiac disease.
    Alaedini A; Green PH; Sander HW; Hays AP; Gamboa ET; Fasano A; Sonnenberg M; Lewis LD; Latov N
    J Neuroimmunol; 2002 Jun; 127(1-2):145-8. PubMed ID: 12044986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA; Wilson R; Prentice RL
    Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
    J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
    Avila JL
    Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?
    Bartolomei F; Boucraut J; Barrié M; Kok J; Dravet C; Viallat D; Bernard D; Gastaut JL
    Epilepsia; 1996 Oct; 37(10):922-6. PubMed ID: 8822688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum IgG antibodies to GD1a and GM1 gangliosides in elderly people].
    Kolyovska V
    Biomed Khim; 2016; 62(1):93-5. PubMed ID: 26973195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a natural human antibody with anti-galactosyl(alpha 1-2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection.
    Avila JL; Rojas M; Velazquez-Avila G
    Am J Trop Med Hyg; 1992 Oct; 47(4):413-21. PubMed ID: 1279994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
    Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
    J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
    Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
    Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
    Matà S; Lolli F; Söderström M; Pinto F; Link H
    Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
    Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
    J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection.
    Gisslén M; Lekman A; Fredman P
    Infection; 2000; 28(3):143-8. PubMed ID: 10879637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.